Immunogen

Lilly reunites with ImmunoGen to expand into ADCs, paying $13M upfront and $1.7B on the back end
Fierce Biotech
Tue, 02/15/22 - 10:35 am
Eli Lilly
Immunogen
antibody-drug conjugate
ImmunoGen lines up FDA filing as antibody-drug conjugate shrinks tumors in pivotal trial
Fierce Biotech
Tue, 11/30/21 - 10:29 am
Immunogen
mirvetuximab soravtansine
ovarian cancer
FDA
antibody-drug conjugate
After weathering failure, rejection and layoffs, ImmunoGen touts a new 'breakthrough' drug in its comeback plan
Endpoints
Mon, 10/5/20 - 10:57 am
Immunogen
FDA
IMGN632
blastic plasmacytoid dendritic cell neoplasm
ImmunoGen cuts deep to eke out cash for mirvetuximab trial
Fierce Biotech
Thu, 06/27/19 - 11:37 am
Immunogen
R&D
layoffs
A delicate balancing act for Immunogen
EP Vantage
Tue, 05/21/19 - 09:33 am
Immunogen
mirvetuximab soravtansin
Jazz Pharmaceuticals
IMGN779
IMGN632
FDA tells ImmunoGen to run a second phase 3, sinking stock
Fierce Biotech
Wed, 05/15/19 - 10:38 am
Immunogen
mirevtuximab soravtansine
ovarian cancer
clinical trials
ImmunoGen Plunges After Phase III Ovarian Cancer Treatment Fails to Hit PFS Endpoint
BioSpace
Fri, 03/1/19 - 10:16 am
Immunogen
ovarian cancer
clinical trials
mirvetuximab soravtansine
ImmunoGen Waits to Leap "Forward"
Motley Fool
Sat, 11/10/18 - 12:46 pm
Immunogen
earnings
Synaffix Adds Antibody Drug Conjugate Veteran John Lambert to Scientific Advisory Board
CP Wire
Mon, 05/14/18 - 09:29 am
Synaffix
Immunogen
antibody-drug conjugate
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
CP Wire
Fri, 04/27/18 - 01:18 pm
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
Fri, 04/27/18 - 01:19 pm
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 02/18/18 - 10:09 am
Alkermes
Immunogen
Sorrento Therapeutics
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
Jazz, ImmunoGen partner on hematology, oncology drug development
BioPharma Dive
Wed, 08/30/17 - 11:46 pm
Jazz Pharmaceuticals
Immunogen
oncology
hematology
drug development
Why ImmunoGen, Inc. Jumped Higher Today
Motley Fool
Tue, 07/25/17 - 12:01 am
Immunogen
anetumab ravtansine
Bayer
mesothelioma
5 Best Biotech Stocks of 2017 So Far
Motley Fool
Mon, 06/26/17 - 09:41 am
biotech
Alnylam
Puma Biotechnology
Immunogen
Sangamo BioSciences
Calitera
Sanofi beefs up cancer drug pipeline, paying cash hungry ImmunoGen $30M for full rights to oncology portfolio
Endpoints
Tue, 05/30/17 - 10:40 am
Sanofi
Immunogen
oncology
M&A
isatuximab
Multiple Myeloma
ImmunoGen’s new CEO retrenches, axing 65 staffers and looking to thin pipeline
Endpoints
Fri, 09/30/16 - 09:43 am
Immunogen
layoffs
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Fri, 05/20/16 - 11:36 am
Boston
biotech
ASCO 2016
Ariad Pharmaceuticals
Immunogen
Ziopharm
Vertex Pharmaceuticals
Tokai
Infinity Pharmaceuticals
Momenta
Merrimack
Tesaro
Syndax
Kyropharm
Foundation Medicine
Cerulean Pharma
8 Biotech Stocks Under $10 Making Big Moves Higher
TheStreet.com
Sun, 03/20/16 - 01:16 pm
Dicerna
Novadaq Technologies
Idera Pharmaceuticals
Versartis
ProNai
Immunogen
Medgenic
Inotek

Pages